Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

Historical Holders from Q3 2023 to Q3 2025

Symbol
BNTC on Nasdaq
CUSIP
08205P209
Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
27.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
23.2M
Holdings value
$325M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
54
Number of buys
31
Number of sells
-16
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 44.1% -11.6% $249M $30M 17.8M +13.7% SUVRETTA CAPITAL MANAGEMENT, LLC Nov 7, 2025
FRANKLIN RESOURCES INC 14.9% -8.75% $58.1M -$3.8M 4.14M -6.14% Franklin Resources, Inc. Sep 30, 2025
JANUS HENDERSON GROUP PLC 11.3% -0.91% $37.8M -$210K 2.9M -0.55% JANUS HENDERSON GROUP PLC Jun 30, 2025
HBM Healthcare Investments (Cayman) Ltd. 4.5% $13.6M 1.04M HBM Healthcare Investments (Cayman) Ltd. Dec 31, 2024
Nantahala Capital Management, LLC 4.39% -52.6% $13.5M 1.04M 0% Nantahala Capital Management, LLC Mar 31, 2025

Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23.2M $325M +$6.87M $14.03 54
2025 Q2 22.7M $265M +$16.7M $11.70 56
2025 Q1 21.2M $277M +$28.3M $13.01 37
2024 Q4 19M $240M +$64.6M $12.63 30
2024 Q3 13.7M $127M +$73.4M $9.19 25
2024 Q2 5.73M $39.9M +$31.1M $6.99 18
2024 Q1 1.27M $6.58M +$345K $5.25 13
2023 Q4 1.2M $3.88M -$231K $3.23 13
2023 Q3 1.27M $3.84M +$3.84M $3.02 11